Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AH Neuraminidase inhibitors
J05AH02 Oseltamivir
D00900 Oseltamivir phosphate (JAN/USP) <JP/US>
USP drug classification [BR:br08302]
Antivirals
Anti-influenza Agents
Oseltamivir
D00900 Oseltamivir phosphate (JAN/USP)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
625 Antivirals
6250 Antivirals
D00900 Oseltamivir phosphate (JAN/USP)
Drug groups [BR:br08330]
Antiviral
DG03029 Anti-influenza virus agent
DG02842 Neuraminidase inhibitor
DG00665 Oseltamivir
D00900 Oseltamivir phosphate
Drug classes [BR:br08332]
Antiviral
DG03029 Anti-influenza virus agent
D00900 Oseltamivir phosphate
Antimicrobials [BR:br08307]
Antivirals
Virus release inhibitor
Neuraminidase inhibitor
D00900 Oseltamivir phosphate (JAN/USP) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D00900
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D00900
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D00900
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D00900